FDA Adverse Event Injury Summary report: N

APTIMA HPV SCREENING ASSAY

MDR report key: 24575801 · Received March 11, 2026

Report

Report Number
2024800-2026-00011
Event Type
Injury
Date Received
March 11, 2026
Date of Event
January 20, 2026
Report Date
March 11, 2026
Manufacturer
HOLOGIC, INC.
Product Code
OYB
PMA / PMN Number
P100042
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

HOLOGIC TS REVIEWED THE SYSTEM LOG FILES PROVIDED BY THE CUSTOMER, AND PRELIMINARY ANALYSIS INDICATES THAT THE MOST LIKELY EXPLANATION FOR THE DISCREPANT RESULT IS EITHER A LOW TARGET CONCENTRATION IN THE SAMPLE NEAR THE LIMIT OF DETECTION OR THAT THE SAMPLE WAS MISHANDLED/CONTAMINATED. REVIEW OF THE LOGS AND KINETIC CURVE DATA DID NOT REVEAL ANY HARDWARE OR INSTRUMENT ISSUES THAT CONTRIBUTED TO THE DISCREPANT RESULT.

Description of Event or Problem · 0

ON (B)(6) 2026, A CUSTOMER IN FRANCE REPORTED TO HOLOGIC THAT DISCREPANT RESULTS WERE GENERATED WHILST USING THE APTIMA HUMAN PAPILLOMAVIRUS (HPV) ASSAY, MASTER LOT (ML) 922916 WITH PANTHER INSTRUMENT (SERIAL NUMBER: (B)(6). THE INCIDENT WAS RECORDED UNDER HOLOGIC REFERENCE NUMBER (B)(4). ON 20 JANUARY 2026, SAMPLE ID (B)(6) WAS TESTED ON HPV WORKLIST ID (B)(6) AND GENERATED AN HPV NEGATIVE RESULT. THE SAME SAMPLE (ID (B)(6) WAS RETESTED ON (B)(6) 2026 ON THE PANTHER INSTRUMENT (WORKLIST ID (B)(4) AND GENERATED AN HPV POSITIVE RESULT. THE CUSTOMER DID NOT REPORT ANY RESULTS TO THE PATIENT PRIOR TO RETESTING. NO INFORMATION REGARDING PATIENT TREATMENT IS AVAILABLE AT THIS TIME. HOLOGIC HAS NOT BEEN INFORMED OF ANY ADVERSE PATIENT OUTCOME RELATED TO THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
222788 APTIMA HPV SCREENING ASSAY KIT, RNA DETECTION, HUMAN PAPILLOMAVIRUS OYB HOLOGIC, INC. 922916

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other